1. Home
  2. CRBU vs DHX Comparison

CRBU vs DHX Comparison

Compare CRBU & DHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRBU
  • DHX
  • Stock Information
  • Founded
  • CRBU 2011
  • DHX 1991
  • Country
  • CRBU United States
  • DHX United States
  • Employees
  • CRBU N/A
  • DHX N/A
  • Industry
  • CRBU Medicinal Chemicals and Botanical Products
  • DHX Business Services
  • Sector
  • CRBU Health Care
  • DHX Consumer Discretionary
  • Exchange
  • CRBU Nasdaq
  • DHX Nasdaq
  • Market Cap
  • CRBU 93.0M
  • DHX 89.7M
  • IPO Year
  • CRBU 2021
  • DHX 2007
  • Fundamental
  • Price
  • CRBU $1.63
  • DHX $2.93
  • Analyst Decision
  • CRBU Strong Buy
  • DHX Strong Buy
  • Analyst Count
  • CRBU 4
  • DHX 2
  • Target Price
  • CRBU $8.50
  • DHX $5.25
  • AVG Volume (30 Days)
  • CRBU 1.9M
  • DHX 105.2K
  • Earning Date
  • CRBU 08-05-2025
  • DHX 08-06-2025
  • Dividend Yield
  • CRBU N/A
  • DHX N/A
  • EPS Growth
  • CRBU N/A
  • DHX N/A
  • EPS
  • CRBU N/A
  • DHX N/A
  • Revenue
  • CRBU $9,918,000.00
  • DHX $138,202,000.00
  • Revenue This Year
  • CRBU $9.52
  • DHX N/A
  • Revenue Next Year
  • CRBU N/A
  • DHX $0.88
  • P/E Ratio
  • CRBU N/A
  • DHX N/A
  • Revenue Growth
  • CRBU N/A
  • DHX N/A
  • 52 Week Low
  • CRBU $0.66
  • DHX $1.21
  • 52 Week High
  • CRBU $3.00
  • DHX $3.34
  • Technical
  • Relative Strength Index (RSI)
  • CRBU 66.57
  • DHX 58.87
  • Support Level
  • CRBU $1.34
  • DHX $2.85
  • Resistance Level
  • CRBU $1.79
  • DHX $2.99
  • Average True Range (ATR)
  • CRBU 0.12
  • DHX 0.21
  • MACD
  • CRBU 0.03
  • DHX -0.02
  • Stochastic Oscillator
  • CRBU 72.84
  • DHX 49.39

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.

About DHX DHI Group Inc.

DHI Group Inc is a provider of artificial intelligence-powered software products, online tools and services to deliver career marketplaces to candidates and employers globally. DHI's brands includes Dice and Clearance Jobs enable recruiters and hiring managers to efficiently search, match and connect with skilled technologists in specialized fields, particularly technology and those with active government security clearances. The company derive the majority of revenue came from the sale of recruitment packages, which allow customers to promote jobs on websites and source candidates through their resume databases. Recruitment packages are typically provided through contractual arrangements with annual, quarterly or monthly payment terms.

Share on Social Networks: